Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mengmeng Yue
Institutions:
Hubei University of Medicine,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital
Observed institutions:
Hubei University of Medicine,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital
ORCID:
0009-0007-5665-2998
Observed ORCID:
0009-0007-5665-2998
OpenAlex ID:
A5077390382
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes
2023
·
Zijun Ma
, Kaiqin Jin
, et al.
·
Journal of Diabetes Research
·
29
The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus
2024
·
Mengmeng Yue
, Xianzhen He
, et al.
·
Frontiers in Immunology
·
15
PDF
An Association Between GLP-1 Receptor Expression on Regulatory T Cells and the Severity of Coronary Artery Stenosis and Inflammatory Dysregulation in Coronary Heart Disease
2025
·
Mingzhu Lv
, Mengmeng Yue
, et al.
·
Reviews in Cardiovascular Medicine
·
4
PDF
Show more works
View as search
Works count:
3
Citation count:
48
H-index:
3
I10-index:
2
Year
Topic
Type